ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "damage"

  • Abstract Number: 023 • 2020 Pediatric Rheumatology Symposium

    Capturing the Range of Disease Involvement in Localized Scleroderma: The Total Morbidity Score

    Suzanne Li1, Aashka Patel 2, Elena Pope 3, Thomas Mason 4, Vidya Sivaraman 5, Fatma Dedeoglu 6, Kathryn Torok 7, Katie Stewart 8, Gloria Higgins 9, C. Egla Rabinovich 10, Robert Fuhlbrigge 11, Maria Ibarra 12, Sandy Hong 13, Polly Ferguson 14, Mara Becker 15, Brian Feldman 16 and Ronald Laxer 17 for the CARRA investigators, 1Joseph M. Sanzari Children's Hospital Hackensack Meridian Health, Hackensack, 2Hackensack University Medical Center, Hackensack, 3Hospital For Sick Kids, Toronto, Canada, 4Rochester, 5Division of Rheumatology, Nationwide Children's Hospital, Bexley, 6Boston Children's Hospital, Boston, 7Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, 8UT Southwestern, Dallas, 9Nationwide Childrens Hospital/ The Ohio State University, Columbus, 10Duke University Hospital, Durham, 11University of Colorado, Aurora, 12Children's Mercy Kansas City, Kansas City, 13University of Iowa Stead Family Children's Hospital, Iowa City, 14University of Iowa Carver College of Medicine, Iowa City, 15Duke University Medical Center/Duke Clinical Research Institute, Chapel Hill, 16The Hospital for Sick Children, Toronto, Canada, 17The Hospital for Sick Children and University of Toronto, Toronto, Canada

    Background/Purpose: Localized scleroderma (LS) is a chronic inflammatory and fibrosing disease that causes both cutaneous and extracutaneous (EC) damage. EC involvement (ECI) is common in…
  • Abstract Number: 757 • 2019 ACR/ARP Annual Meeting

    Long-term Clinical Course and Outcomes of 2013 Patients with Takayasu Arteritis

    Hajime Yoshifuji1, Haruhito Uchida 2, Yoshikazu Nakaoka 3, Takahiko Sugihara 4, Mitsuaki Isobe 5 and Masayoshi Harigai 6, 1Kyoto University, Kyoto, Japan, 2Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 3National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan, 4Tokyo Medical and Dental University, Tokyo, Japan, 5Sakakibara Heart Institute, Tokyo, Japan, 6Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan

    Background/Purpose: Takayasu arteritis (TAK) occurs at a young age and has a long-term clinical course. Progression of arterial stenosis or dilatation leads to organ dysfunction.…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies